NasdaqGM:ORKABiotechs
Oruka Therapeutics (ORKA) Files $1b Shelf As Investors Weigh A Pricey Valuation
Oruka Therapeutics (ORKA) has filed a universal shelf registration for up to US$1 billion in common and preferred stock, depositary shares and warrants. This filing gives the company flexibility to raise capital when needed.
See our latest analysis for Oruka Therapeutics.
Oruka Therapeutics shares trade at US$107.96 after a 78.12% 90 day share price return and a very large 1 year total shareholder return, with recent gains pointing to strong momentum despite a softer 7 day share price return...